NDC codes

FDA NDC Directory
Product NDC (as listed)72603-259Labeler and product segments. Claims need a package NDC.
Product NDC at billing width72603-0259Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
72603-259-017260302590190 TABLET, FILM COATED in 1 BOTTLE (72603-259-01)Marketed from Jul 1, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Pirfenidone
Generic name (nonproprietary)
pirfenidone
Active ingredients
Pirfenidone — 801 mg/1
Dosage form
Tablet, Film coated
Route
Oral
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 212772
Marketing start
Listing expires
Other FDA classes
Pyridones (Chemical structure)
Identifiers
Product ID 72603-259_5d0eee8c-dc7d-4444-8684-e9c9335291c8SPL ID 5d0eee8c-dc7d-4444-8684-e9c9335291c8SPL set ID 5d0eee8c-dc7d-4444-8684-e9c9335291c8RxCUI 1868014, 1868018UNII D7NLD2JX7UUPC 0372603259018, 0372603258011
Pharmacologic class
Pyridone

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472603025901 followed by a unit qualifier and the quantity

Package 72603-0259-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

Pirfenidone tablet is indicated for the treatment of idiopathic pulmonary fibrosis (IPF). Pirfenidone tablet is a pyridone indicated for the treatment of idiopathic pulmonary fibrosis (IPF). ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 212772

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 212772
ProductStrengthForm · routeLabelerProduct NDC
PirfenidonePirfenidone 267 mg/1Tablet, Film coatedOralNovadoz Pharmaceuticals LLC72205-181
PirfenidonePirfenidone 801 mg/1Tablet, Film coatedOralNovadoz Pharmaceuticals LLC72205-182
PirfenidonePirfenidone 267 mg/1Tablet, Film coatedOralMAJOR PHARMACEUTICALS0904-7397
PirfenidonePirfenidone 801 mg/1Tablet, Film coatedOralMAJOR PHARMACEUTICALS0904-7398
PirfenidonePirfenidone 267 mg/1Tablet, Film coatedOralNorthstar Rx LLC72603-258

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in